K-V Pharmaceutical (KVPHQ) Says Bankruptcy Court Approves Hologic (HOLX) Settlement
K-V Pharmaceutical Company (OTC: KVPHQ) (NYSE: KV-A) today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's settlement agreement with Hologic, Inc. (Nasdaq: HOLX), and authorized the Company to enter into an $85 million debtor-in-possession financing to, among other things, fund the settlement.
You May Also Be Interested In
- Instagram (FB) Debuts New Snapchat-Like Feature
- Coca-Cola (KO) Announces Reorganization of Americas Business; Steve Cahillane Resigns
- Merrimack Pharma (MACK) Issues Encouraging Update on MM-302 Phase 1
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!